To Investigate the Efficacy and Safety of UB-421 Monotherapy in HIV-1 Infected Adults

NCT03149211 · clinicaltrials.gov ↗

PHASE3

Phase

WITHDRAWN

Status

INDUSTRY

Sponsor class

Stopped project adjustment

Conditions

HIV-1 Infection

Interventions

DRUG: UB-421
DRUG: current standard HAART treatment

Sponsor

United BioPharma